Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Grieve

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Health Economics|June 3, 2011
A matching method for improving covariate balance in cost-effectiveness analysesJasjeet Singh Sekhon, Richard D Grieve
Health Economics|April 21, 2009
Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap comparedRichard M Nixon, David Wonderling, Richard D Grieve
BMC Medical Research Methodology|March 19, 2020
A framework for extending trial design to facilitate missing data sensitivity analysesAlexina J Mason, Richard D Grieve, Alvin Richards-Belle, et al.
International Journal of Technology Assessment in Health Care|April 1, 2009
Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practiceMarina Grishchenko, Richard D Grieve, Michael J Sweeting, et al.
Journal of the Intensive Care Society|August 13, 2020
Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Statistical and health economic analysis plan for the 65 trial in articleKaren Thomas, Akshay Patel, M Zia Sadique, et al.
Journal of the Intensive Care Society|June 7, 2021
Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Protocol for the 65 randomised clinical trialAlvin Richards-Belle, Paul R Mouncey, Richard D Grieve, et al.
The New England Journal of Medicine|March 18, 2015
Trial of early, goal-directed resuscitation for septic shockPaul R Mouncey, Tiffany M Osborn, G Sarah Power, et al.
Health Technology Assessment (Winchester, England)|April 20, 2016
A multicentre, randomised controlled trial comparing the clinical effectiveness and cost-effectiveness of early nutritional support via the parenteral versus the enteral route in critically ill patients (CALORIES)Sheila E Harvey, Francesca Parrott, David A Harrison, et al.
JAMA|February 13, 2020
Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical TrialFrançois Lamontagne, Alvin Richards-Belle, Karen Thomas, et al.
Health Technology Assessment (Winchester, England)|November 25, 2015
Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shockPaul R Mouncey, Tiffany M Osborn, G Sarah Power, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Health Economics|June 3, 2011
A matching method for improving covariate balance in cost-effectiveness analysesJasjeet Singh Sekhon, Richard D Grieve
Health Economics|April 21, 2009
Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap comparedRichard M Nixon, David Wonderling, Richard D Grieve
BMC Medical Research Methodology|March 19, 2020
A framework for extending trial design to facilitate missing data sensitivity analysesAlexina J Mason, Richard D Grieve, Alvin Richards-Belle, et al.
International Journal of Technology Assessment in Health Care|April 1, 2009
Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practiceMarina Grishchenko, Richard D Grieve, Michael J Sweeting, et al.
Journal of the Intensive Care Society|August 13, 2020
Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Statistical and health economic analysis plan for the 65 trial in articleKaren Thomas, Akshay Patel, M Zia Sadique, et al.
Journal of the Intensive Care Society|June 7, 2021
Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Protocol for the 65 randomised clinical trialAlvin Richards-Belle, Paul R Mouncey, Richard D Grieve, et al.
The New England Journal of Medicine|March 18, 2015
Trial of early, goal-directed resuscitation for septic shockPaul R Mouncey, Tiffany M Osborn, G Sarah Power, et al.
Health Technology Assessment (Winchester, England)|April 20, 2016
A multicentre, randomised controlled trial comparing the clinical effectiveness and cost-effectiveness of early nutritional support via the parenteral versus the enteral route in critically ill patients (CALORIES)Sheila E Harvey, Francesca Parrott, David A Harrison, et al.
JAMA|February 13, 2020
Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical TrialFrançois Lamontagne, Alvin Richards-Belle, Karen Thomas, et al.
Health Technology Assessment (Winchester, England)|November 25, 2015
Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shockPaul R Mouncey, Tiffany M Osborn, G Sarah Power, et al.
Pageof 2